Strategic Direction

Phacilitate's Protein Therapeutics Form 2013

January 28-30th, 2013

The Protein Therapeutics Forum 2013 is a unique, strategically-focused meeting, which crystallises the competitive landscape for antibodies and other therapeutic proteins in an off-patent world. It is tailored entirely to the information and networking needs of R&D leaders from big pharma and biotech charged with developing new protein-based therapies of all classes.

WHY ATTEND?

  • Now in its second year the Protein Therapeutics Forum will draw on the success of the last meeting to further focus on pipeline and portfolio decision making.

  • An invitation only, senior level speaker faculty will address all the key challenges and opportunities in an entirely plenary setting thereby enabling you to hear each and every speaker, panel discussion and case study.

  • With a tight focus on strategy – around targets, collaboration, demonstrating value, lifecycle management, biosimilar opportunities, the relevance of emerging platform technologies – you will take home your SWOT analysis to drive differentiation, developability and business development.

The Protein Therapeutics Forum is held alongside the Vaccine Forum and the Cell & Gene Therapy Forum. Attendees have unlimited access to all 3 conferences.

To contribute your views to the development of the 2013 program, please email team@phacilitate.co.uk.

For sponsorship and booth information, please also email gaurav@phacilitate.co.uk.

  • Download the 2013 Protein Therapeutics brochure

    Download the 2013 Protein Therapeutics brochure

    Download the 2013 Protein Therapeutics brochure

    Download now

Join our mailing list

  • Endorsed by:

    American Peptide Society
  • Endorsed by:

    The International Society for BioProcess Technology (ISBioTech)
  • Endorsed by:

    The Society For Biomaterials
  • Media Partners:

    BioProcessing Journal
  • Media Partners:

    mAbs
  • Media Partners:

    Pharmalicensing
  • Media Partners:

    www.pharmaphorum.com
  • Media Partners:

    Technology Networks
  • Media Partners:

    The Scientist
  • Supporting Partner:

    Protein Engineering